Literature DB >> 31865849

Development and Calibration of a Dynamic HIV Transmission Model for 6 US Cities.

Xiao Zang1,2, Emanuel Krebs1, Jeong E Min1, Ankur Pandya3, Brandon D L Marshall4, Bruce R Schackman5, Czarina N Behrends5, Daniel J Feaster6, Bohdan Nosyk1,2.   

Abstract

Background. Heterogeneity in HIV microepidemics across US cities necessitates locally oriented, combination implementation strategies to prioritize resources. We calibrated and validated a dynamic, compartmental HIV transmission model to establish a status quo treatment scenario, holding constant current levels of care for 6 US cities. Methods. Built off a comprehensive evidence synthesis, we adapted and extended a previously published model to replicate the transmission, progression, and clinical care for each microepidemic. We identified a common set of 17 calibration targets between 2012 and 2015 and used the Morris method to select the most influential parameters for calibration. We then applied the Nelder-Mead algorithm to iteratively calibrate the model to generate 2000 best-fitting parameter sets. Finally, model projections were internally validated with a series of robustness checks and externally validated against published estimates of HIV incidence, while the face validity of 25-year projections was assessed by a Scientific Advisory Committee (SAC). Results. We documented our process for model development, calibration, and validation to maximize its transparency and reproducibility. The projected outcomes demonstrated a good fit to calibration targets, with a mean goodness-of-fit ranging from 0.0174 (New York City [NYC]) to 0.0861 (Atlanta). Most of the incidence predictions were within the uncertainty range for 5 of the 6 cities (ranging from 21% [Miami] to 100% [NYC]), demonstrating good external validity. The face validity of the long-term projections was confirmed by our SAC, showing that the incidence would decrease or remain stable in Atlanta, Los Angeles, NYC, and Seattle while increasing in Baltimore and Miami. Discussion. This exercise provides a basis for assessing the incremental value of further investments in HIV combination implementation strategies tailored to urban HIV microepidemics.

Entities:  

Keywords:  HIV/AIDS; dynamic transmission model; epidemiological projection; model calibration; model validation

Mesh:

Year:  2019        PMID: 31865849      PMCID: PMC6982595          DOI: 10.1177/0272989X19889356

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  38 in total

1.  Calibrating models in economic evaluation: a seven-step approach.

Authors:  Tazio Vanni; Jonathan Karnon; Jason Madan; Richard G White; W John Edmunds; Anna M Foss; Rosa Legood
Journal:  Pharmacoeconomics       Date:  2011-01       Impact factor: 4.981

Review 2.  Calibration methods used in cancer simulation models and suggested reporting guidelines.

Authors:  Natasha K Stout; Amy B Knudsen; Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs.

Authors:  Gary Marks; Nicole Crepaz; J Walton Senterfitt; Robert S Janssen
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-01       Impact factor: 3.731

4.  Heterogeneous sexual activity models of HIV transmission in male homosexual populations.

Authors:  S P Blythe; R M Anderson
Journal:  IMA J Math Appl Med Biol       Date:  1988

5.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

6.  Sources of racial disparities in HIV prevalence in men who have sex with men in Atlanta, GA, USA: a modelling study.

Authors:  Steven M Goodreau; Eli S Rosenberg; Samuel M Jenness; Nicole Luisi; Sarah E Stansfield; Gregorio A Millett; Patrick S Sullivan
Journal:  Lancet HIV       Date:  2017-04-18       Impact factor: 12.767

Review 7.  Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples.

Authors:  Rebecca F Baggaley; Richard G White; T Déirdre Hollingsworth; Marie-Claude Boily
Journal:  Epidemiology       Date:  2013-01       Impact factor: 4.822

8.  Linked Sensitivity Analysis, Calibration, and Uncertainty Analysis Using a System Dynamics Model for Stroke Comparative Effectiveness Research.

Authors:  Yuan Tian; Kristen Hassmiller Lich; Nathaniel D Osgood; Kirsten Eom; David B Matchar
Journal:  Med Decis Making       Date:  2016-04-18       Impact factor: 2.583

Review 9.  Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.

Authors:  Georgie J MacArthur; Silvia Minozzi; Natasha Martin; Peter Vickerman; Sherry Deren; Julie Bruneau; Louisa Degenhardt; Matthew Hickman
Journal:  BMJ       Date:  2012-10-03

10.  Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections.

Authors:  Rui Fu; Alexander Gutfraind; Margaret L Brandeau
Journal:  Math Biosci       Date:  2016-01-14       Impact factor: 3.935

View more
  15 in total

1.  Prioritizing Additional Data Collection to Reduce Decision Uncertainty in the HIV/AIDS Response in 6 US Cities: A Value of Information Analysis.

Authors:  Xiao Zang; Hawre Jalal; Emanuel Krebs; Ankur Pandya; Haoxuan Zhou; Benjamin Enns; Bohdan Nosyk
Journal:  Value Health       Date:  2020-10-03       Impact factor: 5.725

2.  Dissemination Science to Advance the Use of Simulation Modeling: Our Obligation Moving Forward.

Authors:  Bohdan Nosyk; Janet Weiner; Emanuel Krebs; Xiao Zang; Benjamin Enns; Czarina N Behrends; Daniel J Feaster; Hawre Jalal; Brandon D L Marshall; Ankur Pandya; Bruce R Schackman; Zachary F Meisel
Journal:  Med Decis Making       Date:  2020-08-05       Impact factor: 2.583

3.  Can the 'Ending the HIV Epidemic' initiative transition the USA towards HIV/AIDS epidemic control?

Authors:  Xiao Zang; Emanuel Krebs; Cassandra Mah; Jeong E Min; Brandon D L Marshall; Daniel J Feaster; Bruce R Schackman; Lisa R Metsch; Steffanie A Strathdee; Czarina N Behrends; Bohdan Nosyk
Journal:  AIDS       Date:  2020-12-01       Impact factor: 4.177

4.  "Ending the Epidemic" Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus Epidemic.

Authors:  Bohdan Nosyk; Emanuel Krebs; Xiao Zang; Micah Piske; Benjamin Enns; Jeong E Min; Czarina N Behrends; Carlos Del Rio; Daniel J Feaster; Matthew Golden; Brandon D L Marshall; Shruti H Mehta; Zachary F Meisel; Lisa R Metsch; Ankur Pandya; Bruce R Schackman; Steven Shoptaw; Steffanie A Strathdee
Journal:  Clin Infect Dis       Date:  2020-12-31       Impact factor: 9.079

5.  What Will It Take to End HIV in the United States? : A Comprehensive, Local-Level Modeling Study.

Authors:  Anthony Todd Fojo; Melissa Schnure; Parastu Kasaie; David W Dowdy; Maunank Shah
Journal:  Ann Intern Med       Date:  2021-09-21       Impact factor: 25.391

6.  Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island.

Authors:  Xiao Zang; Alexandria Macmadu; Maxwell S Krieger; Czarina N Behrends; Traci C Green; Jake R Morgan; Sean M Murphy; Shayla Nolen; Alexander Y Walley; Bruce R Schackman; Brandon Dl Marshall
Journal:  Int J Drug Policy       Date:  2021-09-03

7.  Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities.

Authors:  Emanuel Krebs; Xiao Zang; Benjamin Enns; Jeong E Min; Czarina N Behrends; Carlos Del Rio; Julia C Dombrowski; Daniel J Feaster; Kelly A Gebo; Brandon D L Marshall; Shruti H Mehta; Lisa R Metsch; Ankur Pandya; Bruce R Schackman; Steffanie A Strathdee; Bohdan Nosyk
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

8.  Ending the HIV epidemic in the USA: an economic modelling study in six cities.

Authors:  Bohdan Nosyk; Xiao Zang; Emanuel Krebs; Benjamin Enns; Jeong E Min; Czarina N Behrends; Carlos Del Rio; Julia C Dombrowski; Daniel J Feaster; Matthew Golden; Brandon D L Marshall; Shruti H Mehta; Lisa R Metsch; Ankur Pandya; Bruce R Schackman; Steven Shoptaw; Steffanie A Strathdee
Journal:  Lancet HIV       Date:  2020-03-05       Impact factor: 12.767

9.  Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities.

Authors:  Amanda My Linh Quan; Cassandra Mah; Emanuel Krebs; Xiao Zang; Siyuan Chen; Keri Althoff; Wendy Armstrong; Czarina Navos Behrends; Julia C Dombrowski; Eva Enns; Daniel J Feaster; Kelly A Gebo; William C Goedel; Matthew Golden; Brandon D L Marshall; Shruti H Mehta; Ankur Pandya; Bruce R Schackman; Steffanie A Strathdee; Patrick Sullivan; Hansel Tookes; Bohdan Nosyk
Journal:  Lancet HIV       Date:  2021-08-06       Impact factor: 16.070

10.  The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities.

Authors:  Emanuel Krebs; Xiao Zang; Benjamin Enns; Jeong E Min; Czarina N Behrends; Carlos Del Rio; Julia C Dombrowski; Daniel J Feaster; Kelly A Gebo; Matthew Golden; Brandon D L Marshall; Lisa R Metsch; Bruce R Schackman; Steven Shoptaw; Steffanie A Strathdee; Bohdan Nosyk
Journal:  AIDS       Date:  2020-03-01       Impact factor: 4.632

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.